JBS has opened a biotechnology centre in Florianópolis, Brazil, focused on developing applied science across the food production chain.

The facility, named JBS Biotech, will operate in areas including animal health, precision nutrition and functional and alternative proteins. The opening was attended by JBS global CEO Gilberto Tomazoni, J&F shareholder Wesley Batista and JBS Biotech CEO Fernanda Berti.

Located in Sapiens Parque, the site spans more than 4,000 square metres and houses over 20 laboratories. It has been designed to support the full development cycle, from early-stage research through to validation for industrial application, covering disciplines such as cellular and molecular biology, engineering and data analysis.

JBS said the centre’s infrastructure includes next-generation sequencing, molecular analysis and omics capabilities, alongside facilities for cell, microorganism and plant cultures. It also includes a biobank for the storage and management of biological samples.

Research at the site will also focus on converting co-products into higher-value ingredients, such as functional proteins and bioactive compounds, supporting the company’s circular economy approach.

In addition, the centre will contribute to animal health through the development of veterinary products and data-driven tools aimed at improving production efficiency and welfare.

Tomazoni said the centre will focus on developing functional proteins and bioactive ingredients for use in food and supplements, as well as accelerating proof-of-concept projects for industrial-scale applications.

Berti added that the facility will support the development of precision nutrition solutions, including ingredients designed to target specific physiological responses in humans and animals.